COVID-19
Conditions
Interventions
Gubiao Fanggan group:Gubiao Fanggan granule was taken orally, 1 package each time, 2 times a day. One course of treatment and observation was 1 course. According to the patient's condition, external t
Control group:Western medicine was used for symptomatic and supportive treatment (such as atomization, phlegm elimination, balance of water and electrolyte, etc.), and external treatment of traditiona
Sponsors
Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) When the condition of the COVID-19 infected patient is significantly improved, the vital signs are stable, the body temperature is normal for more than 24 hours, and the patient's lung imaging reexamination shows that the acute exudative lesions are significantly improved, the patient may enter the recovery period. (2) The patient was diagnosed as a recovery period syndrome of lung-spleen qi deficiency syndrome. (3) Physical performance score (PS) =2; (4) predicted survival time =3 months; (5) Both sexes, aged 18-75 years old.
Exclusion criteria
Exclusion criteria: (1) Severe and critical cases of COVID-19 infected patients, and TCM syndrome types in the convalescence period belong to patients with deficiency of Qi and Yin and syndrome of cold drink suppressing lung. (2) Patients with other serious organic diseases; (3) participants in other drug trials; (4) immune diseases, allergic constitution, mental disorders; (5) pregnancy, lactation period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement;Physical condition; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of survival;MMRC dyspnea score;The 6-minute walk test was performed;IgA Antibodies;lymphocytes;The 3-month relapse rate;Status of Immunity;Toxic side effects; | — |
Countries
China
Contacts
Public ContactLiu Fang
Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine
Outcome results
None listed